Availability and Access to Respiratory Vaccines in Latin America: Report of the Latin American Forum of Respiratory Societies 2024
Article Sidebar
Main Article Content
Abstract
Introduction: Latin America faces a high burden of preventable respiratory diseases, with influenza, COVID-19, respiratory syncytial virus and pneumococcal being the main causes of morbidity and mortality. While many countries have implemented immunization programs, coverage varies, reflecting disparities in access to vaccines.
Material and Methods: The Asociación Latinoamericana de Tórax (ALAT) and FOLASOR sent a survey to all member societies asking about access, availability, guidelines used, financing of respiratory vaccines, coverage, cold chain control and the role of pulmonology societies in decision-making in National Immunization Programs. A representative of each member society presented the information collected during the ALAT Congress in July 2024.
Results: 14 of 19 member societies presented situational information for each country. Vaccination schedules do not vary much between countries by adapting PAHO/WHO or ACIP/CDC guidelines in their programs, but the availability and coverage of different respiratory vaccines varies significantly. Most respiratory vaccines are available and their financing is the direct or indirect responsibility of the state, although in many countries it is through private practice. The control of the cold chain is the responsibility of the state. Pulmonary societies are not taken into account in decision-making.
Conclusions: Access to and availability of respiratory vaccines is adequate in the region, but there is heterogeneity in their coverage. The active participation of pulmonology societies in decision-making on respiratory vaccines is necessary.
Article Details
Section
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
References
Organización Panamericana de la Salud (OPS). Informe sobre la Carga de Enfermedades Respiratorias en América Latina. [Internet]. [Consultado 3 ene 2025]. Disponible en: https://www.paho.org/
GBD 2019 LRI Collaborators. Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019. Lancet Infect Dis 2022; 22: 1626–47. Doi: 10.1016/ S1473-3099(22)00510-2.
Nogareda F, Gharpure R, Contreras M et al. Seasonal influenza vaccination in the Americas: Progress and challenges during the COVID-19 pandemic. Vaccine 2023;41:4554–4560. Doi: 10.1016/j.vaccine.2023.06.024.
Nogareda F, Ghiselli M, Velandia-González M et al. Seasonal Influenza Vaccination Programs in the Americas: A Platform for Sustainable Life-Course Immunization and Its Role for Pandemic Preparedness and Response. Vaccines 2024;12:1415. Doi: 10.3390/vaccines12121415.
Zeno EE, Nogareda F, Regan A et al. Interim Effectiveness Estimates of 2024 Southern Hemisphere Influenza Vaccines in Preventing Influenza-Associated Hospitalization - REVELAC-i Network, Five South American Countries, March-July 2024. MMWR Morb Mortal Wkly Rep 2024;73(39):861-868. Doi: 10.15585/mmwr.mm7339a1
Bardach A, Ruvinsky S, Palermo MC et al. Invasive pneumococcal disease in Latin America and the Caribbean: Serotype distribution, disease burden, and impact of vaccination. A systematic review and meta-analysis. PLoS One 2024;19(6):e0304978. Doi: 10.1371/journal.pone.0304978.
Rachlin A, Danovaro-Holliday MC, Murphy P, Sodha SV, Wallace AS. Routine Vaccination Coverage — Worldwide, 2021. MMWR Morb Mortal Wkly Rep 2022;71:1396–1400. Doi:10.15585/mmwr.mm7144a2.
Guzman-Holst A, De Antonio R, Prado-Cohrs D et al. Barriers to vaccination in Latin America: A systematic literature review. Vaccine 2020;38(3):470–81.Doi: 10.1016/j.vaccine.2019.10.088.
Vieira de Rezende RP, Mattos GA, De Mello Leal Augusto R et al. Predictors for Seasonal Influenza Vaccination and Reasons for Inadequate Vaccination Coverage Against a Broad Spectrum of Vaccine-Preventable Diseases: A cross-sectional study among a Brazilian cohort of adult patients with systemic lupus erythematosus. Lupus 2019;28(6):794–6. Doi: 10.11 77/0961203319846383.
Daniels NA, Nguyen TT, Gildengorin G et al. Adult immunization in university-based primary care and specialty practices. J Am Geriatr Soc 2004;52:1007Y1012. Doi: 10.1111/j.1532-5415.2004.52273.x.
Chiganer EH, Camargo Ochi B, Llora Lessa C . Influenza and pneumococcal vaccination coverage in Latin American patients with systemic lupus erythematosus: a cross sectional and comparative study Adv Rheumat 2021;61(1):46. Doi: 10.1186/s42358-021-00197-1.
Sosa Liprandi Á, Zaidel EJ, Lopez Santi R et al. Influenza and Pneumococcal Vaccination in Non-Infected Cardiometabolic Patients from the Americas during the COVID-19 Pandemic. A Sub-Analysis of the CorCOVID-LATAMStudy. Vaccines 202; 9:123. Doi: 10.3390/vaccines9020123.